Oncology Institute Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 18 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +17.8% | +7.4% | -0.1% | +3.6% | -0.8% | +2.6% | +4.9% | +0.1% | +5.5% | +10.4% | +6.7% | +9.9% | +6.7% | +5.3% | +2.3% | +4.6% | +10.3% | +4.1% | +1.3% | +0.4% | +4.1% | +14.7% | +14.0% | +3.9% | +3.9% | – | |
| – | +28.0% | +2.0% | -0.3% | +3.3% | -1.4% | +1.5% | +4.9% | +7.6% | -2.6% | +16.2% | +4.4% | +7.3% | +11.3% | +4.9% | +1.5% | +8.1% | +15.8% | +3.5% | 0.0% | +0.1% | +1.8% | +17.4% | +15.0% | +1.3% | +5.5% | – | |
| – | -17.3% | +36.1% | +0.9% | +5.0% | +1.5% | +6.7% | +4.9% | -27.1% | +47.9% | -9.6% | +16.7% | +20.2% | -9.8% | +7.2% | +5.7% | -10.0% | -16.8% | +8.8% | +10.3% | +1.9% | +17.9% | +1.5% | +8.1% | +20.3% | -4.7% | – | |
| – | – | +279.5% | +2.7% | +0.0% | -8.8% | +1,770.2% | -39.8% | +0.0% | +1,854.0% | -4.9% | +12.8% | -7.5% | -2.5% | -0.4% | -1.8% | -0.4% | +1.3% | -2.0% | -4.4% | -6.7% | +2.1% | +6.0% | -6.2% | +11.0% | +0.6% | – | |
| – | +0.2% | -2.8% | +10.0% | +46.2% | -20.5% | +0.4% | +13.1% | +262.0% | -37.4% | -4.4% | +12.4% | +23.0% | +15.4% | -36.0% | -0.5% | -0.8% | +0.9% | -1.8% | -4.0% | -5.9% | +2.2% | +5.7% | -6.1% | +10.0% | -4.9% | – | |
| – | – | – | -609.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -33.7% | +209.1% | -55.5% | -19.8% | -3.7% | -23.1% | +23.3% | -17.6% | +2,354.1% | +63.7% | +8.2% | +0.8% | +0.9% | -28.0% | +2.3% | +6.7% | +5.1% | -47.5% | +376.9% | -66.4% | +2.7% | -0.2% | +0.9% | – | |
| – | – | – | -166.7% | – | – | – | -154.7% | – | – | -128.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -137.0% | – | -179.4% | – | – | +257.8% | +2.4% | -408.9% | – | -117.8% | – | – | – | +125.0% | +36.4% | -332.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -166.4% | – | – | – | -193.0% | – | – | -128.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -95.9% | -5,190.6% | – | +4,760.0% | -125.8% | – | – | -121.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 11, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.